American Journal of Cardiovascular Drugs

Papers
(The H4-Index of American Journal of Cardiovascular Drugs is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A Critical Review of the Efficacy and Safety of Inclisiran29
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study27
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention24
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis23
Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis23
Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence20
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes20
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial19
The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review18
Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension18
Inclisiran: A Review in Hypercholesterolemia18
Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis17
A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent17
Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis16
A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support16
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Liver Cirrhosis: A Systematic Review and Meta-Analysi15
0.031821012496948